These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 37977814)

  • 41. Ganaxolone: First Approval.
    Lamb YN
    Drugs; 2022 Jun; 82(8):933-940. PubMed ID: 35596878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy.
    Aroniadou-Anderjaska V; Figueiredo TH; Apland JP; Braga MF
    Neurobiol Dis; 2020 Jan; 133():104406. PubMed ID: 30798006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intramuscular allopregnanolone and ganaxolone in a mouse model of treatment-resistant status epilepticus.
    Zolkowska D; Wu CY; Rogawski MA
    Epilepsia; 2018 Oct; 59 Suppl 2(Suppl 2):220-227. PubMed ID: 29453777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticonvulsant therapy for status epilepticus.
    Prasad M; Krishnan PR; Sequeira R; Al-Roomi K
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD003723. PubMed ID: 25207925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.
    Claassen J; Hirsch LJ; Emerson RG; Bates JE; Thompson TB; Mayer SA
    Neurology; 2001 Sep; 57(6):1036-42. PubMed ID: 11571331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.
    Bellante F; Legros B; Depondt C; Créteur J; Taccone FS; Gaspard N
    J Neurol; 2016 Apr; 263(4):799-806. PubMed ID: 26914931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Midazolam and pentobarbital for refractory status epilepticus.
    Holmes GL; Riviello JJ
    Pediatr Neurol; 1999 Apr; 20(4):259-64. PubMed ID: 10328273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soman-induced status epilepticus, epileptogenesis, and neuropathology in carboxylesterase knockout mice treated with midazolam.
    Marrero-Rosado B; de Araujo Furtado M; Schultz CR; Stone M; Kundrick E; Walker K; O'Brien S; Du F; Lumley LA
    Epilepsia; 2018 Dec; 59(12):2206-2218. PubMed ID: 30368799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enaminone Modulators of Extrasynaptic α
    Johnstone TBC; McCarren HS; Spampanato J; Dudek FE; McDonough JH; Hogenkamp D; Gee KW
    Front Pharmacol; 2019; 10():560. PubMed ID: 31178732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Refractory status epilepticus.
    Murthy JM
    Neurol India; 2006 Dec; 54(4):354-8. PubMed ID: 17114841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of clobazam for treatment of refractory status epilepticus.
    Madžar D; Geyer A; Knappe RU; Gollwitzer S; Kuramatsu JB; Gerner ST; Hamer HM; Huttner HB
    BMC Neurol; 2016 Oct; 16(1):202. PubMed ID: 27769254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overview of clinical efficacy and risk data of benzodiazepines for prolonged seizures.
    Lagae L
    Epileptic Disord; 2014 Oct; 16 Spec No 1():S44-9. PubMed ID: 25323111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3
    Chuang SH; Reddy DS
    J Pharmacol Exp Ther; 2018 Jun; 365(3):583-601. PubMed ID: 29602830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment.
    Beretta S; Coppo A; Bianchi E; Zanchi C; Carone D; Stabile A; Padovano G; Sulmina E; Grassi A; Bogliun G; Foti G; Ferrarese C; Pesenti A; Beghi E; Avalli L
    Epilepsy Behav; 2019 Dec; 101(Pt B):106374. PubMed ID: 31300383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.